The cash-strapped federal government’s ability to fund stem-cell research has become severely limited, the top official in charge of the research told attendees at the World Stem Cell Summit on Wednesday. So the private sector is being encouraged to play a larger role, to take over some functions, provide order and reduce needless duplication of effort.
Recent Posts
- Stem cells provide a potent treatment for frailty
- Cracking a ‘holy grail’ challenge in cancer cell therapy
- New Bio-Implant for Spinal Cord Repair
- Seattle jury awards $24M in lawsuit against stem cell center
- Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
- After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
